Alto Neuroscience
(NYSE) ANRO
Alto Neuroscience Financials at a Glance
Market Cap
$736.97M
Revenue (TTM)
$0.00
Net Income (TTM)
-$74.31M
EPS (TTM)
-$2.48
P/E Ratio
-8.46
Dividend
$0.00
Beta (Volatility)
1.71 (High)
Dividend
$0.00
Beta (Volatility)
1.71 (High)
Price
$21.03
Volume
267,345.116
Open
$21.25
Price
$21.03
Volume
267,345.116
Open
$21.25
Previous Close
$21.00
Daily Range
$20.67 - $22.13
52-Week Range
$2.15 - $28.44
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
1.71 (High)
Price
$21.03
Volume
267,345.116
Open
$21.25
Previous Close
$21.00
Daily Range
$20.67 - $22.13
52-Week Range
$2.15 - $28.44
Estimated Earnings Date
Aug 12, 2026
ANRO News
ANRO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alto Neuroscience
Industry
Pharmaceuticals
Sector
Health CareEmployees
68
CEO
Amit Etkin, MD, PhD
Website
www.altoneuroscience.comHeadquarters
Mountain View, CA 94022, US
ANRO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-39%
Return on Capital
21%
Return on Assets
-27%
Earnings Yield
-11.82%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$736.97M
Shares Outstanding
35.09M
Volume
267.35K
Avg. Volume
336.18K
Financials (TTM)
Gross Profit
-$661.00K
Operating Income
-$66.36M
EBITDA
-$60.11M
Operating Cash Flow
-$51.77M
Capital Expenditure
-$24.00K
Free Cash Flow
-$51.79M
Cash & ST Invst.
$176.48M
Total Debt
$4.41M
Alto Neuroscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$184.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$736.97M
N/A
Market Cap/Employee
$9.70M
N/A
Employees
76
N/A
Net Income
-$26.24M
-73.0%
EBITDA
-$25.51M
-77.1%
Quarterly Fundamentals
Total Cash
$263.76M
+64.1%
Total Debt
$5.69M
-78.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.56M
-86.1%
Short Term Debt
$2.14M
+143.8%
Return on Assets
-26.90%
N/A
Return on Invested Capital
20.86%
N/A
Free Cash Flow
-$27.65M
-66.7%
Operating Cash Flow
-$27.09M
-63.6%